Inhibitors of CDK8/19, by suppressing the activity of CDK8/19, hold the potential to intervene in abnormal gene expression, regulate cell proliferation and survival, thus providing new therapeutic avenues and possibilities for cancer treatment. This evidence concerns the gene CDK8 and cancer.